NCT01111799

Brief Summary

It was previously demonstrated in in vitro fertilization (IVF) patients that local injury of the endometrium during a spontaneous menstrual cycle that precedes IVF treatment doubled the rates of implantation and pregnancy. The hypothesis of our present study is that the endometrial injury procedure will have the same beneficial effect in patients undergoing controlled ovarian hyperstimulation (COH) combined with intrauterine insemination (IUI).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
600

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2010

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 21, 2010

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 28, 2010

Completed
1 month until next milestone

Study Start

First participant enrolled

June 1, 2010

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2012

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2012

Completed
Last Updated

March 16, 2012

Status Verified

March 1, 2012

Enrollment Period

2.3 years

First QC Date

April 21, 2010

Last Update Submit

March 15, 2012

Conditions

Keywords

endometrial biopsyimplantationuterine receptivityinfertilitycontroled ovarian hyperstimulationintra uterine insemination

Outcome Measures

Primary Outcomes (1)

  • Clinical Pregnancy rate

    1 year

Secondary Outcomes (1)

  • Live birth

    2 years

Study Arms (6)

Clomiphene citrate + IUI + endometrial biopsy

EXPERIMENTAL

Clomiphene citrate + IUI + endometrial biopsy

Procedure: endometrial biopsy

Clomiphene citrate + IUI

NO INTERVENTION

gonadotrophines + IUI + endometrial biopsy

EXPERIMENTAL

two endometrial biopsies will be taken with a PIPELLE catheter on days 12 and 21 of the spontaneous menstrual cycle that precedes the fertility treatment.

Procedure: endometrial biopsy

gonadotrophines + IUI

NO INTERVENTION

natural cycle + IUI + endometrail biopsy

EXPERIMENTAL

two endometrial biopsies will be taken with a PIPELLE catheter on days 12 and 21 of the spontaneous menstrual cycle that precedes the fertility treatment.

Procedure: natural cycle + IUI + endometrial biopsy

natural cycle + IUI

NO INTERVENTION

Interventions

two endometrial biopsies will be taken with a PIPELLE catheter on days 12 and 21 of the spontaneous menstrual cycle that precedes the fertility treatment.

Clomiphene citrate + IUI + endometrial biopsy

two endometrial biopsies will be taken with a PIPELLE catheter on days 12 and 21 of the spontaneous menstrual cycle that precedes the fertility treatment.

natural cycle + IUI + endometrail biopsy

Eligibility Criteria

Age18 Years - 38 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • age 18-38.
  • infertility.
  • patients undergoing IUI treatment.
  • at least one failed IUI cycle.

You may not qualify if:

  • indication for IVF treatment.
  • Known Pelvic inflammatory disease(PID).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Remez women medical center

Rehovot, Israel

RECRUITING

Related Publications (1)

  • Barash A, Dekel N, Fieldust S, Segal I, Schechtman E, Granot I. Local injury to the endometrium doubles the incidence of successful pregnancies in patients undergoing in vitro fertilization. Fertil Steril. 2003 Jun;79(6):1317-22. doi: 10.1016/s0015-0282(03)00345-5.

    PMID: 12798877BACKGROUND

MeSH Terms

Conditions

Infertility

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital Diseases

Study Officials

  • Yuval Or, MD

    Clalit health service

    STUDY DIRECTOR

Central Study Contacts

Leila Aliger, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 21, 2010

First Posted

April 28, 2010

Study Start

June 1, 2010

Primary Completion

September 1, 2012

Study Completion

October 1, 2012

Last Updated

March 16, 2012

Record last verified: 2012-03

Locations